chartexchange

MaxCyte To Acquire Akron

RTTNews | Nov 10, 2026 6:18 AM EST


(RTTNews) - MaxCyte, Inc. (MXCT) has entered into a definitive agreement to acquire Akron BioProducts LLC from affiliates of Arcline Investment Management for total consideration of $151.8 million. At the close of the transaction, MaxCyte will pay $105.0 million in cash, subject

Read original article